Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		144,806,464
Beginning balance at Dec. 31, 2023	$ 1,155,610	$ 15	$ 2,295,807	$ (1,375)	$ (1,138,837)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		471,310
Exercise of stock options	7,140		7,140
Stock-based compensation	42,590		42,590
Issuance of common stock upon settlement of restricted stock units (in shares)		994,029
Other comprehensive income (loss)	(693)			(693)
Net loss	(10,966)				(10,966)
Ending balance (in shares) at Mar. 31, 2024		146,271,803
Ending balance at Mar. 31, 2024	1,193,681	$ 15	2,345,537	(2,068)	(1,149,803)
Beginning balance (in shares) at Dec. 31, 2023		144,806,464
Beginning balance at Dec. 31, 2023	1,155,610	$ 15	2,295,807	(1,375)	(1,138,837)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(43,665)
Ending balance (in shares) at Sep. 30, 2024		148,663,793
Ending balance at Sep. 30, 2024	1,285,649	$ 15	2,468,450	(314)	(1,182,502)
Beginning balance (in shares) at Mar. 31, 2024		146,271,803
Beginning balance at Mar. 31, 2024	1,193,681	$ 15	2,345,537	(2,068)	(1,149,803)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		294,901
Exercise of stock options	2,779		2,779
Stock-based compensation	52,721		52,721
Issuance of common stock upon settlement of restricted stock units (in shares)		835,497
Issuance of common stock for employee stock purchase plan (in shares)		276,349
Issuance of common stock for employee stock purchase plan	13,187		13,187
Other comprehensive income (loss)	(259)			(259)
Net loss	(6,311)				(6,311)
Ending balance (in shares) at Jun. 30, 2024		147,678,550
Ending balance at Jun. 30, 2024	1,255,798	$ 15	2,414,224	(2,327)	(1,156,114)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		195,852
Exercise of stock options	2,452		2,452
Stock-based compensation	51,774		51,774
Issuance of common stock upon settlement of restricted stock units (in shares)		789,391
Other comprehensive income (loss)	2,013			2,013
Net loss	(26,388)				(26,388)
Ending balance (in shares) at Sep. 30, 2024		148,663,793
Ending balance at Sep. 30, 2024	1,285,649	$ 15	2,468,450	(314)	(1,182,502)
Beginning balance (in shares) at Dec. 31, 2024		149,853,135
Beginning balance at Dec. 31, 2024	1,288,353	$ 15	2,535,868	(2,737)	(1,244,793)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		149,650
Exercise of stock options	2,352		2,352
Stock-based compensation	52,402		52,402
Issuance of common stock upon settlement of restricted stock units (in shares)		882,979
Shares withheld related to net share settlement of equity awards (in shares)		(331,056)
Shares withheld related to net share settlement of equity awards	(28,277)		(28,277)
Repurchase and retirement of common stock, including transaction costs and excise tax (in shares)		(1,450,591)
Repurchase and retirement of common stock, including transaction costs and excise tax	(100,440)		(100,440)
Other comprehensive income (loss)	246			246
Net loss	(32,989)				(32,989)
Ending balance (in shares) at Mar. 31, 2025		149,104,117
Ending balance at Mar. 31, 2025	1,181,647	$ 15	2,461,905	(2,491)	(1,277,782)
Beginning balance (in shares) at Dec. 31, 2024		149,853,135
Beginning balance at Dec. 31, 2024	$ 1,288,353	$ 15	2,535,868	(2,737)	(1,244,793)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	561,356
Repurchase and retirement of common stock, including transaction costs and excise tax (in shares)	(1,903,527)
Repurchase and retirement of common stock, including transaction costs and excise tax	$ (128,800)
Net loss	(63,179)
Ending balance (in shares) at Sep. 30, 2025		150,457,845
Ending balance at Sep. 30, 2025	1,224,023	$ 15	2,533,616	(1,636)	(1,307,972)
Beginning balance (in shares) at Mar. 31, 2025		149,104,117
Beginning balance at Mar. 31, 2025	1,181,647	$ 15	2,461,905	(2,491)	(1,277,782)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		335,896
Exercise of stock options	5,218		5,218
Stock-based compensation	60,651		60,651
Issuance of common stock upon settlement of restricted stock units (in shares)		865,285
Issuance of common stock for employee stock purchase plan (in shares)		245,276
Issuance of common stock for employee stock purchase plan	14,404		14,404
Shares withheld related to net share settlement of equity awards (in shares)		(313,050)
Shares withheld related to net share settlement of equity awards	(21,577)		(21,577)
Repurchase and retirement of common stock, including transaction costs and excise tax (in shares)		(48,503)
Repurchase and retirement of common stock, including transaction costs and excise tax	(2,721)		(2,721)
Other comprehensive income (loss)	1,066			1,066
Net loss	(21,089)				(21,089)
Ending balance (in shares) at Jun. 30, 2025		150,189,021
Ending balance at Jun. 30, 2025	1,217,599	$ 15	2,517,880	(1,425)	(1,298,871)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		75,810
Exercise of stock options	1,172		1,172
Stock-based compensation	61,537		61,537
Issuance of common stock upon settlement of restricted stock units (in shares)		927,954
Shares withheld related to net share settlement of equity awards (in shares)		(330,507)
Shares withheld related to net share settlement of equity awards	(21,318)		(21,318)
Repurchase and retirement of common stock, including transaction costs and excise tax (in shares)		(404,433)
Repurchase and retirement of common stock, including transaction costs and excise tax	(25,655)		(25,655)
Other comprehensive income (loss)	(211)			(211)
Net loss	(9,101)				(9,101)
Ending balance (in shares) at Sep. 30, 2025		150,457,845
Ending balance at Sep. 30, 2025	$ 1,224,023	$ 15	$ 2,533,616	$ (1,636)	$ (1,307,972)